Cancer and Embolic Stroke of Undetermined Source
Stroke 52:1121-1130, Navi,B.B.,et al, 2021
DWI Lesion Patterns in Cancer-Related Stroke-Specifying the Phenotype
Cerebrovasc Dis Extra 5:139-145, Schwarzbach, C.J.,et al, 2015
Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Cancer
Neurol 83:26-33, Navi, B.B.,et al, 2014
Stroke as the First Manifestation of Concealed Cancer
J Neurol Sci 258:80-83, Kwon, H.M.,et al, 2007
Stroke as the First Manifestation of a Concealed Pancreatic Neoplasia
Rev Neurol 38:332-335, Perez-Lazaro,C.,et al, 2004
Surgical Treatment of Atrioesophageal Fistula:A Systematic Review
Ann Thorac Surg 116:421-428, Amirkhosravi,F.,et al, 2023
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke
Ann Neurol 88:946-955, Triantafyllou, S.,et al, 2020
A 62-year-old man with history of catheter ablation presenting with recurrent strokes
Neurol 95:e3065-e3069, Jeanneret, V.,et al, 2020
Ischemic Stroke and Internal Carotid Artery Web
Stroke 50:e31-e34, Mc Grory, B.,et al, 2019
Recurrent Ischemic and Hemorrhagic Strokes in a Young Adult
JAMA Neurol 75:628-629, Rocha, E.A. & Singhal, A.B., 2018
Embolic Stroke of Undetermined Source
Stroke 48:867-872, Hart, R.G.,et al, 2017
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016
Emerging Risk Factors for Recurrent Vascular Events in Patients with Embolic Stroke of Unertermined Source
Stroke 47:2714-2721, Ueno, Y.,et al, 2016
Risk of Recurrent Neurologic Stroke or Transient Ischemic Attack in Patients with Cryptogenic Stroke and Intrapulmonary Shunt
Echocardiography 33:276-280, Sinha, R.S.,et al, 2015
Lambls Excrescense Associated with Cryptogenic Stroke
Am J Case Rep 16:876-881, Chu, A.,et al, 2015
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
NEJM 370:911-920, Zhou, Q.,et al, 2014
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis: Report of 7 Cases and Review of the Literature
Medicine 87:335-344, Solans-Laque,R.,et al, 2008
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Frequency and Mechanisms of Stroke Recurrence After Cryptogenic Stroke
Ann Neurol 54:227-234, Bang,O.Y.,et al, 2003
Cardiac Papillary Fibroelastoma as a Cause of Recurrent Ischemic Strokes: The Diagnostic Value of Serial Transesophageal Echocardiography
Cerebrovasc Dis 14:256-259, Baba, Y.,et al, 2002
Transient Ischaemic Attack in a Young Woman
Lancet 355:622, Lee,P. & Tse, H., 2000
Cerebral Infarction in Young Adults
Neurol 50:890-894, Kittner,S.J.,et al, 1998
Clinicopath Conf,Syndrome of Mitochondrial Encephalopathy,Lactic Acidosis,and Stroke-Like Episodes (MELAS),Case 39-1998
NEJM 339:1914-1923, , 1998
Surgical Closure of Patent Foramen Ovale in Cryptogenic Stroke Patients
Stroke 28:2376-2381, Homma,S.,et al, 1997
Cerebrovascular Complications of Fabry's Disease
Ann Neurol 40:8-17, Mitsias,P.&Levine,S.R., 1996
Should Cerebral Ischemic Events in Cancer Patients be Considered a Manifestation of Hypercoagulability
Stroke 25:1215-1218, Chaturvedi,S.,et al, 1994
Clinicopathologic Conference, Paraneoplastic Vasculitis of the Central Nervous System
NEJM 388:747-757, Case 6-2023, 2023
Evaluation and Treatment of a Patient with Recurrent Stroke in the Setting of Active Malignancy
Stroke 50:e9-e11, Neilson, L.E.,et al, 2019
Ischemic Stroke in Cancer Patients: A Review of an Underappreciated Pathology
Ann Neurol 83:873-883, Navi, B.B. & Iadecola, C., 2018
A 66-year-old man with Recurrent Multi-Territory Infarcts
Neurol 84:e195-e201, Kouzmitcheva, E.,et al, 2015
Recurrent Stroke in Childhood Cancer Survivors
Neurol 85:1056-1064, Fullerton, H.J.,et al, 2015
Atrial Myxoma
MedLink July, Muengtaweepongsa, S.,et al, 2011
FDG-PET a Pivotal Imaging Modality for Diagnosis of Stroke-Onset Intravascular Lymphoma
Arch Neurol 67:366-367, Yamada,S.,et al, 2010
Childhood Posterior Circulation Arterial Ischemic Stroke
Stroke 41:2201-2209, Mackay,M.T.,et al, 2010
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Stroke Syndrome Secondary to Hypercoagulability of Lung Cancer
Commun Oncol 5:595-596, Lim, B. & Henry, D.H., 2008
Embolic Stroke Secondary to Cardiac Papillary Fibroelastoma
Neurologist 14:128-130, Zurru, M.C.,et al, 2008
Primary Systemic Amyloidosis With Ischemic Stroke as a Presenting Complication
Neurol 69:1136-1141, Yubkov,A.Y.,et al, 2007
Recurrent Hemorrhagic Stroke in Children: A Population-Based Cohort Study
Stroke 38:2658-2662, Fullerton,H.J.,et al, 2007